Press release
Hearing Loss Pipeline 2025: Groundbreaking Clinical Advancements by 30+ Global Leaders - DelveInsight | Featuring Sensorion, AudioCure Pharma GmbH, Acousia Therapeutics, Neuracle Science, Regeneron Pharmaceuticals, Sound Pharmaceuticals, PAEAN Biotechnolo
Hearing Loss Pipeline 2025, DelveInsight
DelveInsight's "Hearing Loss Pipeline Insight 2025" report provides a detailed and strategic evaluation of the ongoing R&D landscape. It covers clinical trial progression, emerging therapies, mechanisms of action, competitive positioning, and key company initiatives. The report serves as a crucial resource for stakeholders, including researchers, healthcare investors, and decision-makers, seeking insights into the evolving Hearing Loss Therapeutics Market and the breakthroughs shaping its future trajectory.
Explore the Cutting-Edge Landscape of Hearing Loss Drug Development @ https://www.delveinsight.com/report-store/hearing-loss-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Key Takeaways from the Hearing Loss Pipeline Report
DelveInsight's Hearing Loss pipeline report depicts a robust space with 30+ active players working to develop 35+ pipeline therapies for Hearing Loss treatment.
In February 2025, Sound Pharmaceuticals revealed it will present four studies at the upcoming Association for Research in Otolaryngology MidWinter Meeting. A highlight among these is a session titled "The Development of SPI-1005 for the Treatment of Hearing Loss and Tinnitus," featured at the Pharmaceutical Interventions for Hearing Loss (PIHL) Satellite Symposium. This event is hosted by the Defense Health Agency's (DHA) Hearing Center of Excellence (HCE) and will spotlight cutting-edge research into therapies designed to prevent hearing loss and enhance auditory recovery.
In January 2025, Eirion Therapeutics, a U.S.-based dermatology biopharma firm, announced successful results from its first-in-human clinical trial for its topical therapy ET-02, aimed at treating age-related hair loss. In a randomized, double-blind, placebo-controlled study involving 24 men across three clinical sites, the treatment demonstrated a six-fold increase in hair density compared to placebo, while also meeting primary safety and tolerability endpoints.
Key Hearing Loss companies such as Sensorion, AudioCure Pharma GmbH, Acousia Therapeutics, Neuracle Science, Regeneron Pharmaceuticals, Sound Pharmaceuticals, PAEAN Biotechnology, and others are evaluating new drugs for Hearing Loss to improve the treatment landscape.
Promising Hearing Loss pipeline therapies in various stages of development include SENS-401, ACOU-085, NS101, and others.
Hearing Loss Overview:
Hearing loss refers to the partial or complete inability to hear sounds, which can be present from birth or develop later in life. It may affect one or both ears and is typically categorized into several types based on the location and cause of impairment:
Download the Hearing Loss sample report to know in detail about the Hearing Loss treatment market @ https://www.delveinsight.com/sample-request/hearing-loss-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Hearing Loss Pipeline Analysis
The Hearing Loss pipeline insights report 2025, provides insights into:
Provides comprehensive insights into key companies developing therapies in the Hearing Loss Market.
Categorizes Hearing Loss therapeutic companies by development stage: early, mid, and late-stage.
Highlights major companies involved in targeted therapy development, including both active and inactive (paused/discontinued) projects.
Reviews emerging Hearing Loss drugs under development based on:
Stage of development
Hearing Loss Route of administration
Target receptor
Monotherapy vs. combination therapy
Hearing Loss Mechanism of action
Molecular type
Offers detailed analysis of:
Company-to-company and company-academia collaborations
Hearing Loss Licensing agreements
Funding and investment activities supporting future Hearing Loss market advancement.
Unlock key insights into emerging Hearing Loss therapies and market strategies here: https://www.delveinsight.com/report-store/hearing-loss-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Hearing Loss Emerging Drugs
SENS-401: Sensorion
SENS-401 is an orally administered small molecule developed by Sensorion to protect and maintain inner ear tissue against damage that leads to progressive or residual hearing impairment. The drug is designed to mitigate hearing loss caused by various insults, particularly chemotherapy-related toxicity and surgical interventions.
ACOU-085: Acousia Therapeutics
ACOU085 is a first-in-class small-molecule drug designed to offer broad-spectrum otoprotection, regardless of the cause (etiology). It is administered through a standard transtympanic route, using a proprietary slow-release gel formulation that delivers the treatment directly to the middle ear.
Hearing Loss Pipeline Therapeutic Assessment
Hearing Loss Assessment by Product Type
• Mono
• Combination
• Mono/Combination
Hearing Loss By Stage
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I) along with the details of
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Hearing Loss Assessment by Route of Administration
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical
Hearing Loss Assessment by Molecule Type
• Recombinant fusion proteins
• Small molecule
• Monoclonal antibody
• Peptide
• Polymer
• Gene therapy
Download sample pages to get an in-depth assessment of the emerging Hearing Loss therapies and key Hearing Loss companies: https://www.delveinsight.com/sample-request/hearing-loss-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Table of Contents
1. Report Introduction
2. Executive Summary
3. Hearing Loss Current Treatment Patterns
4. Hearing Loss - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Hearing Loss Late-Stage Products (Phase-III)
7. Hearing Loss Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Hearing Loss Discontinued Products
13. Hearing Loss Product Profiles
14. Hearing Loss Key Companies
15. Hearing Loss Key Products
16. Dormant and Discontinued Products
17. Hearing Loss Unmet Needs
18. Hearing Loss Future Perspectives
19. Hearing Loss Analyst Review
20. Appendix
21. Report Methodology
Request the sample PDF to get detailed insights about the Hearing Loss pipeline reports offerings: https://www.delveinsight.com/report-store/hearing-loss-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Contact Info:
Kritika Rehani
Assistant Manager, Marketing & Branding
krehani@delveinsight.com
info@delveinsight.com
+14699457679
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hearing Loss Pipeline 2025: Groundbreaking Clinical Advancements by 30+ Global Leaders - DelveInsight | Featuring Sensorion, AudioCure Pharma GmbH, Acousia Therapeutics, Neuracle Science, Regeneron Pharmaceuticals, Sound Pharmaceuticals, PAEAN Biotechnolo here
News-ID: 4106348 • Views: …
More Releases from DELVEINSIGHT
X-Linked Adrenoleukodystrophy Pipeline Insight 2025: A New Era of Gene Therapy a …
X-Linked Adrenoleukodystrophy (X-ALD) is a rare, inherited metabolic disorder caused by mutations in the ABCD1 gene, leading to the accumulation of very long-chain fatty acids (VLCFAs) that damage the adrenal cortex and white matter of the brain. The disorder predominantly affects males and manifests in multiple phenotypes, including the severe childhood cerebral form, adrenomyeloneuropathy (AMN), and Addison-only disease. Without timely intervention, cerebral X-ALD can progress rapidly, leading to severe neurological…
Cytokine Release Syndrome Pipeline Insight 2025: Advancing Therapeutics to Manag …
Cytokine Release Syndrome (CRS) is a life-threatening systemic inflammatory response often associated with CAR-T cell therapies and other immunotherapies. It is characterized by a surge of cytokines, including IL-6 and IFN-γ, leading to symptoms ranging from mild flu-like illness to severe multi-organ dysfunction. As cell and gene therapies continue to expand across oncology and autoimmune indications, addressing CRS has become a top priority for both safety and treatment sustainability.
The current…
Biliary Atresia Pipeline Insight 2025: Emerging Regenerative and Anti-Fibrotic T …
Biliary atresia is a rare and life-threatening pediatric liver disease characterized by progressive fibro-obliteration of the bile ducts, leading to cholestasis, fibrosis, and ultimately liver failure. Typically diagnosed within the first few months of life, the condition is managed initially through the Kasai portoenterostomy. However, in many cases, this surgical intervention only delays the need for liver transplantation, which remains the definitive treatment.
As of 2025, the drug development landscape for…
Familial Chylomicronemia Syndrome Pipeline Insight 2025: RNA Therapies and Gene …
DelveInsight's "Familial Chylomicronemia Syndrome - Pipeline Insight, 2025" offers a comprehensive overview of the rapidly advancing therapeutic landscape targeting this ultra-rare autosomal recessive disorder, characterized by extreme hypertriglyceridemia and recurrent pancreatitis due to lipoprotein lipase (LPL) deficiency or dysfunction.
The 2025 pipeline is led by novel RNA interference (RNAi) and antisense oligonucleotide (ASO) therapies designed to silence key regulators of triglyceride metabolism, such as APOC3 and ANGPTL3. Ionis Pharmaceuticals' olezarsen (targeting…
More Releases for Hearing
Doctors Hearing Care: Local Hearing Experts Patients Can Trust
Image: https://www.globalnewslines.com/uploads/2025/08/1754678091.jpg
NEW ALBANY, IN - Doctors Hearing Care is proud to serve as a trusted provider of expert hearing healthcare in the heart of New Albany, Indiana. With a team composed entirely of licensed audiologists holding doctoral degrees, the clinic continues to lead the way in delivering personalized, compassionate care for individuals experiencing hearing loss, tinnitus, and balance concerns.
The clinic emphasizes a patient-centered approach, where each individual is treated with…
Audio Help Hearing Centers Elevates Hearing Care with Expert Audiologists and Ad …
Image: https://www.globalnewslines.com/uploads/2025/05/1748357801.jpg
NEW YORK, NY - Audio Help Hearing Centers, a trusted leader in hearing healthcare, continues to set the standard for excellence by offering comprehensive hearing services through its team of expert audiologists. With convenient locations across Chelsea, Columbus Circle, Park Avenue, Scarsdale, and Stamford, Audio Help remains committed to delivering personalized care and the latest in hearing aid technology.
At Audio Help Hearing Centers [https://www.audiohelphearing.com/], patients receive individualized attention from…
Dr George Hearing Centers Expands Hearing Solutions with Custom ITE And Canal He …
Image: https://www.globalnewslines.com/uploads/2025/03/1742895322.jpg
Dr. George Hearing Centers expands its offerings with discreet and high-quality solutions for hearing loss.
Larnaca - March 25, 2025 - Dr. George Hearing Centers recently announced their expansion of innovative hearing solutions with custom In-the-Ear (ITE) and Canal Hearing Aids. This addition to their product lineup reflects the company's endeavour to providing high-quality, personalised hearing care for individuals experiencing hearing loss. The lineup includes Invisible-in-the-canal (IIC), Completely-in-the-canal (CIC), In-the-canal…
Ontario Hearing Centers in Rochester, NY: Delivering Exceptional Hearing Care an …
Image: https://www.globalnewslines.com/uploads/2025/01/1737435436.jpg
Rochester, NY - Ontario Hearing Centers is proud to be a trusted provider of comprehensive hearing care in Rochester, NY. As a locally owned practice with decades of experience, Ontario Hearing Centers continues to set the standard for personalized audiology services and cutting-edge hearing aid technology in the region.
At the heart of Ontario Hearing Centers' success is its commitment to helping individuals improve their quality of life through better…
Global Wireless Hearing Aid Market Driving Future Growth on Wireless Hearing Aid …
Global Wireless Hearing Aid Market 2025:
Global Wireless Hearing Aid Industry Market professional research 2015-2025, is a report which provides the details about industry overview, industry chain, market size (sales, revenue, and growth rate), gross margin, major manufacturers, development trends and forecast.
PDF Copy Available at Disconted Price Check Discount @ https://www.marketgrowthinsight.com/discount/90344
The Global Wireless Hearing Aid Market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of…
Smart Hearing Aids Market Development Insight and Manufacturers Challenges By Ke …
Recent research and the current scenario as well as future market potential of "Global Smart Hearing Aids Market Professional Survey Report 2019".
The Smart Hearing Aids Market comprehensively describes the market and prognosticates it to depict a highly illustrious growth during the forthcoming years. The report offers in-depth analysis of current and future Smart Hearing Aids Market outlook across the globe. The report is projected to help readers with the regions…
